A new push by doctors and researchers last week on a Food and Drug Administration panel pushed the agency to remove what they ...

In 2002, 30 to 40 percent of menopausal women in the U.S. were on hormone therapy, Lee says. Now, it’s less than 5 percent, according to the Menopause Society, an organization that educates health ...

A new study shows that using tirzepatide together with menopause hormone therapy can lead to greater weight loss in postmenopausal women who are overweight or have obesity. These findings were shared ...

Hormone therapies for menopause have come with black box warnings for decades. Our wellness expert explains why this could ...

This approach of using a name to label and identify a health issue has had success in the past. In 2012, a team of experts ...

Columnist Jen Cueva says that with PH and heart problems, hormone replacement therapy isn't an option. She has other helpful tips, though.

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But GLP-1s can be an effective reinforcement of diet and exercise.

The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

The contrast between the FDA’s clinical lens and the raw realities in the Bonafide study highlights a critical disconnect ...

A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...